1-9 of 9
Janice Ward
Close
Sort by
Journal Articles

Chronic Graft- Versus -Host Disease after Allogeneic Stem Cell Transplant with in Vivo T-Cell Depletion By Alemtuzumab: Incidence, Outcome and Pattern of Organ Involvement

Maria Chiara Finazzi, MD, Cristina Boschini, MSc, Janice Ward, BSc, Charles Craddock, MDPhD, Alessandro Rambaldi, MD, Ram Malladi, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3912.
https://doi.org/10.1182/blood.V124.21.3912.3912
Published: 2014
Journal Articles

ABO Blood Group Mismatch Does Not Affect Survival Or Transfusion Requirements In Patients Undergoing Alemtuzumab-Based Reduced-Intensity Conditioned Hematopoietic Stem Cell Transplantation

Charlotte K Brierley, Timothy J Littlewood, Andrew Peniket, Richard Gregg, Janice Ward, Andrew Clark, Anne Parker, Ram Malladi, Patrick G Medd
Journal: Blood
Blood (2013) 122 (21): 3352.
https://doi.org/10.1182/blood.V122.21.3352.3352
Published: 2013
Journal Articles

Defining The Optimal Dose Of Alemtuzumab In Unrelated Donor Reduced Intensity Allografts: A UK Retrospective Study

Kile Green, BSc(Hons), Rob Sellar, MD, Laura Jardine, MD, Janice Ward, Paul Ferguson, MD, Pip Nicolson, MD, Kim Pearce, PhD, Venetia Bigley, MD, PhD, Graham Jackson, MD, Sandeep Nagra, MD, Anne M Dickinson, PhD, Kirsty Thomson, MD, Stephen Mackinnon, MD, Charles Craddock, MD, Matthew P. Collin, MD, PhD, Karl S Peggs, MD
Journal: Blood
Blood (2013) 122 (21): 4540.
https://doi.org/10.1182/blood.V122.21.4540.4540
Published: 2013
Journal Articles

Pre-Transplant Rituximab Is Associated with a Greatly Reduced Risk of Epstein-Barr Virus Reactivation Following Allogeneic Stem Cell Transplantation

David Burns, Shabeeha Rana, Andrew Howman, Sandeep Nagra, Janice Ward, Husam Osman, Yusri Taha, Jenny Byrne, Emma Das-Gupta, Manoj Raghavan, Ram Malladi, Mark Cook, Prem Mahendra, Nigel H. Russell, MD, Charles Craddock, Christopher Fox, Sridhar Chaganti
Journal: Blood
Blood (2012) 120 (21): 460.
https://doi.org/10.1182/blood.V120.21.460.460
Published: 2012
Journal Articles

Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative- Allogeneic Hematopoietic Cell Transplantation

Charlotte Ann Bradbury, MA BM BCh MRCP FRCPATH, Janice Ward, Paresh Vyas, DPhil, FRCP, FRCPath, Nigel H. Russell, MD, Grimwade David, Robert K Hills, Alan K. Burnett, Charles F. Craddock, BM, MRCP, MRCPath, Freeman Sylvie
Journal: Blood
Blood (2012) 120 (21): 4098.
https://doi.org/10.1182/blood.V120.21.4098.4098
Published: 2012
Journal Articles

Outcomes of Eam Conditioned Autologous Haematopoietic Stem Cell Transplantation for Lymphoma. A Matched Pairs Retrospective Single Centre Study Analysis.

Justin Ching Ting Loke, BM BCh, Janice Ward, Prem Mahendra, Sridhar Chaganti, Ram Malladi
Journal: Blood
Blood (2012) 120 (21): 3088.
https://doi.org/10.1182/blood.V120.21.3088.3088
Published: 2012
Journal Articles

Reduced Intensity Allogeneic Tranplants Are Well Tolerated In Patients Over the Age of 60: Identification of Factors Predicting Overall Survival

Emmanouil Nikolousis, Sandeep Nagra, Janice Ward, Fiona L Dignan, MD, Bronwen E. Shaw, PhD, MRCP, FRCPath, Simon Littlewood, Jenny Byrne, MD, PhD, Maria Helena Gilleece, MD, FRCPath, MB, BSc, FRCP, Eleni Tholouli, Fiona Clark, Mark Cook, Premini Mahendra, MD, Gordon Cook, MD, John Yin, MD, Nigel H. Russell, MD, Charles Craddock
Journal: Blood
Blood (2010) 116 (21): 2361.
https://doi.org/10.1182/blood.V116.21.2361.2361
Published: 2010
Journal Articles

Cyclosporine dose Intensity Is a Critical Determinant of Outcome after a T Cell Depleted Reduced Intensity Allograft.

Charles F. Craddock, BM, MRCP, MRCPath, Sandeep Nagra, Cassandra Brookes, Nick Duncan, Alison H Thomson, Prem Mahendra, Janice Ward, Fiona Clark, Paul Moss, Mark Cook
Journal: Blood
Blood (2008) 112 (11): 1153.
https://doi.org/10.1182/blood.V112.11.1153.1153
Published: 2008
Journal Articles

Factors Predicting Long Term Survival after Reduced Intensity Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia.

Charles F. Craddock, MD, PhD, Sudhir Tauro, MDPhD, Joanne E. Gregory, Laura Buckley, PhD, Janice Ward, BSc(Hons), Panos Kottaridis, MDPhD, Eleni Thelouli, MDPhD, Kirsty Thomson, MDPhD, Donald Milligan, MDPhD, Emma Das-Gupta, MDPhD, Effie Liakpopoulou, MDPhD, John Snowden, MDPhD, John Yin, MDPhD, Andrew Peniket, MDPhD, Mark Cook, MDPhD, Stephen MacKinnon, MDPhD, Nigel H. Russell, MDPhD
Journal: Blood
Blood (2007) 110 (11): 326.
https://doi.org/10.1182/blood.V110.11.326.326
Published: 2007